Decoding the ATT Landscape: Mechanisms, Evidence, and the Evolving Role of Pharmacy
Alzheimer’s disease (AD) affects more than 55 million individuals worldwide, leading to progressive decline in memory, cognition, and ability to perform activities of daily living (ADLs). Recent advancements in amyloid-targeting therapies (ATTs) have created new opportunities to alter disease progression …